RSLS - Amid Ozempic's 'Miracle' Weight-Loss Craze This Company Peaked Over 100% In Tuesday Pre-Market After Receiving Approval For Obesity Treatment | Benzinga
ReShape Lifesciences Inc. (NASDAQ:RSLS) was trading over 117% in the pre-market a day after it received the nod from the U.S. Patent And Trademark Office to issue a patent for its obesity treatment.
What Happened: ReShape, which offers products and services for managing and treating obesity and metabolic diseases, received approval to apply for a patent for its “intragastric devices” for treating obesity. However, this is subject to payment of a fee which ...